International Network of VENous Thromboembolism Clinical Research Networks

SAVER

Statins for Venous Event Reduction in Patients with Venous Thromboembolism

Registration:

(Clinicaltrials.gov) NCT04319627

Sponsors:

Ottawa Hospital Research Institute

Status:

  • Pilot trial recruitment completed in Canada and Norway
  • Secured Funding to Begin Full Trial

Design

A multicentre, prospective, randomized, double-blinded, placebo controlled trial of rosuvastatin (20 mg) for prevention of recurrent VTE (primary outcome), PTS and arterial vascular events (secondary outcomes).

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Canada,

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.